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Multiplexed droplet Interface bilayer formation†
Nathan E. Barlow,ab Guido Bolognesi,ab Anthony J. Flemming,bc
Nicholas J. Brooks,ab Laura M. C. Barterab and Oscar Ces*ab
We present a simple method for the multiplexed formation of
droplet interface bilayers (DIBs) using a mechanically operated
linear acrylic chamber array. To demonstrate the functionality of
the chip design, a lipid membrane permeability assay is performed.
We show that multiple, symmetric DIBs can be created and
separated using this robust low-cost approach.
A droplet interface bilayer (DIB), first developed by Bayley1
and Takeuchi,2 is a fluid bilayer structure that can be
employed in an array of in vitro biological and chemical
experimentation where lipid membranes are necessary. DIBs
are composed of aqueous droplets containing small
unilameller vesicles (SUVs) immersed in oil solutions forming
lipid monolayers at the interface. When these monolayers are
pushed together they form a model membrane bilayer.1
The use of low cost plastics such as polymethyl methacry-
late (PMMA) as a construction material for milli- and micro-
fluidic devices is well established3–8 and a number of such
devices have been recently proposed for the construction and
manipulation of DIBs. In 2010, Sarles and Leo designed a
PMMA chip to contain and stabilize DIBs with physical en-
capsulation; as an unintended consequence of durability test-
ing it was discovered that by shaking at 20 Hz a DIB could be
rendered into its individual droplets.9 This procedure was
not shown to be reproducible, and it is therefore not suitable
for rapid and on-demand DIB separation and re-formation, a
requirement for serial high throughput analysis of lipid
membranes. The controlled and repetitive formation of DIBs
was demonstrated in a circular acrylic DIB well chip (DWC)
by Tsuji et al.10 This “split-and-contact” method was
employed to form, divide and re-form large (40 μL) DIBs rap-
idly for serial pore conductance experimentation with high
statistical relevancy. The chip is size limited however, as it re-
quires relatively large droplets in conjunction with a protec-
tive sheet between the droplets to control the interfacial area
and stabilize the DIB. The resulting DIBs with large droplet
volumes and small interfacial areas are not suitable for all
applications, in particular membrane permeability assays re-
quire the opposite due to diffusion timescale limitations. A
recent design by Czekalska et al. has the ability to repetitively
and automatically form DIBs – one at a time – on a milled,
polycarbonate chip for transmembrane electrical recordings,
the droplets being subsequently separated after use.11 De-
spite their advantages of low-cost and ease of fabrication, the
existing plastic devices can only house a limited number of
DIBs and the statistical data of the membrane properties can
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Fig. 1 Cartoon of movable chamber with aqueous droplets preloaded
in (a) which can be mechanically operated to align the chambers (b)
where a DIB can form. A micrograph image of a DIB is shown (c). The
aqueous droplets in oil are coated with lipid monolayers which will
form a bilayer at the interface of the droplets (d).
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only be accessed through repetitive membrane formation and
serial data acquisition.
Nisisako et al. developed a chip for high-throughput pas-
sive permeability measurements on nL scale DIBs,12 the re-
sults of which demonstrate moderate statistical strength on
improved time scales as compared to parallel artificial mem-
brane permeability assay (PAMPA) techniques.13 The limita-
tion, however, is the inability to simply vary the lipid or per-
meating solute without having to make changes to the
microfluidic system inputs. Finally, this chip does not have
the ability to reversibly return the droplets back into their
original form.
This study in contrast applies a low cost, linear movable
PMMA chamber array chip to allow for the simultaneous for-
mation and analysis of sub-μL DIBs. The device capabilities
are demonstrated by performing small molecule membrane
permeability assays with different lipid compositions. By
parallelising the DIB formation, rapid and high throughput
analysis of the membrane transport properties could be
achieved.
As shown in Fig. 1(a and b), multiple DIBs (c) can be
formed in unison by mechanical action where lipid mono-
layer coated aqueous droplets in oil – manually pipetted into
the device – come into contact to form a bilayer (d) without
mechanical stabilization or area control.
Note that to form asymmetric membranes, DIBs can be
formed with droplets of differing lipid composition.
The chip is fashioned of three laser cut PMMA parts, a
base, stationary chamber and a movable manifold as shown
in Fig. 2. A photograph of the finished product with an array
of 11 × 14 semi-circle chambers 1 mm in diameter is shown
in Fig. 2(b and c). The base and stationary chambers were
sealed together via acetone solvent bonding.14 The number
of wells can be custom designed to accommodate a range of
working areas depending upon the application. The movable
chambers can be actuated by hand with tweezers, a fine in-
strument, or can be rigged with a screw adjustment mecha-
nism. The free standing movable manifold is cut to fit with a
tolerance of 100 μm. After use, the chip can be rinsed with
ethanol, dried and reused. Details of fabrication are supplied
in the ESI.†
To demonstrate the chip function, snapshots of the dy-
namic formation are shown in Fig. 3 where aqueous 1,2-
diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) lipid emul-
sion droplets in hexadecane are put into contact to form in-
terfaces, and then reversibly rendered apart to return to their
original droplet arrangement. From position (a) to position
(b), after sufficient incubation time the nascent droplets form
monolayers (approximately 2 minutes) and can be moved at
an arbitrary rate. To prevent droplet coalescence, care must
be taken when traversing from position (b) to (c). In a study
by Schlicht and Zagnoni, it has been experimentally shown
that for 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and
DPhPC lipids at 5 mg mL−1, the droplet approach velocities
above 100 micrometres per second increase the chances of
DIB coalescence substantially.15 This implies that the oscula-
tion process should take no less than approximately 10 sec-
onds. From image (c) to (d) the bilayer interface forms, which
takes typically less than a minute for this “lipid-in”1 system
in hexadecane, but can vary on different surfaces. Image (e)
demonstrates the effect of lateral shearing forces on the DIB
without mechanical stabilization by an inner plate between
the droplets as used in previous studies.10 The result of
these forces show the interface shrink, and in image (f) the
two droplets are separated. Bilayer formation process dy-
namics have been studied previously,16–18 and it has likewise
been shown that the bilayer area can be modified on DIBs
away from the thermodynamically favourable shape18 by me-
chanical forces19 or electric potential.20 The free energy
landscape is however yet to be explored when the interface
is sheared or indeed whether there are any associated hys-
teresis effects. As a proof of concept, it is shown that the
movable chamber chip can be used for multiplexing DIB
permeability assays. The DIB formation and assay were
performed simultaneously with DOPC and DPhPC, both
lipids shown previously to form stable DIBs.21 All lipids and
Fig. 2 Cartoon of movable chamber chip assembly (a). Photograph of
movable PMMA chamber manifold (b) and stationary chamber (c). The
chip is assembled by solvent bonding of the base and stationary
chamber where the movable part fits inside the stationary chamber
and is free to move laterally.
Fig. 3 Micrograph images of DIB formation dynamics where DPhPC
emulsion droplets are deposited in adjacent chambers (b) which are
brought together by mechanical movement of the top array. (c) The
droplets osculate (d) and form DIBs. (e) The DIBs can be pulled apart
again (f) by moving the top row back to the original position.
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lipid extrusion equipment were purchased from Avanti Polar
Lipids. For DIB preparation, the lipids are first deposited
from chloroform on a glass vial surface and emulsified in
an aqueous phosphate (100 mM) buffer solution at 10 mg
mL−1. The emulsions are prepared by lipid extrusion re-
peated 11× through a 100 nm pore to form a solution
containing approximately 120 nm diameter SUVs. Then the
fluorescent dye 7-hydroxy-3H-phenoxazin-3-one (resorufin),
purchased from Sigma Aldrich, is prepared in solutions at 5
and 0.63 μM.
For the permeability assay, 200 nL droplets are deposited
into the chambers, which consists of a set of DOPC DIBs and
DPhPC DIBs loaded with 5 or 0.65 μM resorufin, which is
within the linear region of fluorescence intensity with respect
to concentration. Fluorescence images (excitation 556 nm
and detection 580 nm) are obtained from laser scanning with
a Typhoon FLA 9500 biomolecular imager – an example im-
age is available in the ESI.† To measure permeability, a sim-
ple mathematic treatment of Fick's first law is employed sim-
ilar to the approach taken by Cass et al.22 By standard
solutions to first order differential equations, the rate of
change of the fluorescence intensity [I]i in a droplet (i = 1, 2)
is given by
(1)
for a given constant ci and initial relative intensity [I]i0, with
respect to time t. Here the rate constant k [s−1] is propor-
tional to the effective permeability P [cm s−1] weighted by the
ratio of interfacial area to droplet volume, k = PA/V. Note that
the effective permeability takes into account the intrinsic
membrane permeability as well as the resistance to mass
transport due to unstirred layers.23,24
The relative fluorescence intensity dynamics of the DIB
pair droplets [I]1 and [I]2 over a span of 25 minutes are plot-
ted in Fig. 4 and are based on the measured fluorescence
data taken using ImageJ pixel analysis. Additionally, the drop-
let volume and interfacial area measurements are taken from
these images. To abate photobleaching, a minimal sample ac-
quisition rate is chosen. Accordingly dynamic intensity data
taken at five time points is used to solve for the rate constant
k with a minimization of the root mean square error of the
model. The permeability data shows the effect of the mem-
brane type, specifically the DPhPC membranes are less per-
meable to resorufin than DOPC, with permeability values of
0.78 ± 0.17 and 1.26 ± 0.23 × 10−4 cm s−1 respectively. The
higher permeability for DOPC confirms previous compari-
sons with norfloxacin.25 Note that this experiment was re-
peated 14 times for DOPC and 6 times for DPhPC, and the
overall error comes from one standard deviation of experi-
mental repeats on freshly made chips. Note also that the
measured permeability value, due to the manifestation of an
unstirred layer effect, is an underestimated value of the in-
trinsic permeability, particularly for higher permeability
membranes, and should be taken as an unstirred, effective
value.26 Despite this underestimate, a Welch's t-test shows an
error rate of 0.001, which bolsters the supposition that there
is a statistically significant difference between the two mea-
surements. Furthermore, this result matches to an order of
magnitude to an unstirred permeability measurement made
by Bean et al. in 1968 with a similar small molecule, indole-
3-ethanol (MW 161), across a planar brain lipid bilayer at 2.9
to 3.5 × 10−4 cm s−1.27 Additionally, as shown by the relatively
rapid diffusion half-life (ca. 10 minutes) with sub-μL DIBs
and interfacial areas on length scales comparable to the
droplet volumes, it is apparent that for small molecule per-
meability assays, a low droplet volume to interfacial area ra-
tio is necessary to attain reasonable timescales.28 This oc-
cludes the use of relatively large droplets for permeability
studies, such as the 40 μL droplets with 250 μm membranes
interfaces used by Tsuji.10
With the proposed low-cost PMMA-based movable cham-
ber chip, high-throughput permeability assays can be
performed at high statistical relevance. Indeed, compared to
other PMMA-based devices, the design of our chip maximises
the space available to DIBs so that a large number (theoreti-
cally ca. 100) of model lipid membranes could be simulta-
neously analysed. Unlike many previous PDMS and glass de-
vices for on-chip multi-DIB formation and characterisation,
requiring a clean-room for construction and a plasma source
for bonding,29,30 our device was manufactured and assem-
bled in a standard laboratory environment with simple proce-
dures and equipment. This is expedient as it opens up our
microfluidic approach for multiplexed DIB formation and
membrane characterisation to a wider scientific community
who do not have access to specialized facilities.
The ability to render the original droplets from a DIB pair
extends the versatility and applicability of the device. For
Fig. 4 An example of relative fluorescence intensity dynamics of
resorufin in donor droplet 1 (solid symbol) and acceptor droplet 2
(empty symbol) where a bilayer is formed from pure DOPC (green
square) and pure DPhPC (black triangle) DIBs (n = 8). The k values are
fit to a first order rate law with a root mean square error minimization,
where together with the droplet volume and area, the permeability is
measured to be 1.08 and 1.40 × 10−4 s−1 for DPhPC and DOPC
respectively. Note that the fit is shifted to cross t = 0 for clarity.
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instance, the transport process of molecules across the mem-
brane could be stopped when the pre-selected amount of fluo-
rescent solute is transferred from the donor to the acceptor
droplets, thereby enabling the control over the final droplet sol-
ute concentration. Additionally, if a permeating solute cannot
be fluorescently labelled, a permeability assay could be designed
where the diffusion could be halted by rendering DIB droplets
at intervals and concentration measurements taken with FTIR,
mass spectrometry or NMR among other techniques.
Microfluidic devices employing the parallel formation of
several artificial membranes in the form of either planar lipid
bilayers31,32 or DIBs30,33 can typically produce only identical
copies of the same lipid system and hence they do not allow
for the parallel analysis of membrane transport with different
lipid types and permeating molecules. This is however desir-
able for pharmacological applications such as high through-
put screening of drug candidates. Conversely, as demon-
strated by the permeability assays, our chip enables the
simultaneous characterisation of the properties of several
membranes composed of different lipid types. By the same
token, the effects of different droplet contents could also be
tested at the same time.
Conclusions
It has been demonstrated that a laser cut PMMA chip can be
deployed to manipulate DIBs for multiplexed formation and
membrane transport analysis. Bilayer interface shearing and
rendering of the original sub-μL droplets was also demon-
strated. The device was manufactured and assembled with
rapid, simple and inexpensive procedures, which do not re-
quire access to advanced fabrication facilities (i.e. cleanroom).
The application of this low cost linear movable chamber chip
to multiplexed membrane permeability assays with different
lipid combinations shows the practicality of simultaneous DIB
formation for membrane transport studies that require high
statistical relevance. Classically, permeability is known to be a
function of solute de-solvation, lipophilicity, molecular volume
and dipole moment,34 however the effect of membrane proper-
ties such as asymmetry on permeability have experienced re-
cent interest.35,36 Accordingly, this chip could be applied for
rapid and quantitative analysis of membrane transport medi-
ated by lipid asymmetry. Furthermore, it could be applied to
high-throughput screening of drug–membrane and protein–
membrane interactions as well as by membrane proteins in-
cluding ion-channels,37 α-hemolysin38 or MscL.39 Finally, the
droplet format would also enable the encapsulation of bio-
synthetic systems with cell-like functions (e.g. gene expression,
enzymatic cascades, etc.), thereby making our device a suitable
platform for bottom-up synthetic biology studies.
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